Physician profile
Mark V Sofonio
NPI 1700868718
$4,539.29
in general payments reported to CMS, 2019-2025
20 companies · $326 in 2025
The $326 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,177 · 2020: $243 · 2021: $698 · 2022: $512 · 2023: $196 · 2024: $1,387 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,908.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,139.12 | 2019-2022 | |
| Revance Therapeutics, INC. | $876.05 | 2024-2025 | Daxxify |
| Merz North America, INC. | $812.99 | 2019-2025 | |
| Galderma Laboratories, L.P. | $581.12 | 2019-2025 | Dysport |
| Abbvie INC. | $195.66 | 2023-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Davol INC. | $190.08 | 2022 | |
| Amgen INC. | $168.16 | 2023-2024 | Krystexxa, Evenity, Prolia |
| Novo Nordisk INC | $118.46 | 2024 | Wegovy |
| Mentor Worldwide LLC | $84.53 | 2022-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Tela Bio, INC. | $74.46 | 2019 | |
| Motiva USA, LLC | $60.72 | 2025 | |
| Sientra, INC. | $59.26 | 2022 | |
| Medtronic, INC. | $34.61 | 2025 | Progrip |
| Conmed Corporation | $26.58 | 2023 | Visiclear, Conmed Pads and Pencils |
| Innovation Technologies INC | $23.76 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $21.03 | 2022 | |
| Coopersurgical, INC. | $20.05 | 2025 | Onetrac Lx |
| Solta Medical, A Division of Bausch Health US, LLC | $19.03 | 2019 | |
| Abbott Laboratories | $16.85 | 2024 | Octrode |
| Apyx Medical Corporation | $16.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Sofonio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.